RecruitingNCT07250958
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage Observational Study
Sponsor
University of Louisville
Enrollment
30 participants
Start Date
Mar 12, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- years or older
- CT confirmed aSAH with an angiographically detected aneurysm
- World Federation of Neurological Sciences (WFNS) aSAH grade 3-5 aneurysm
- LAR available and gives consent within 72 hours after the onset of aSAH (or last known normal
Exclusion Criteria4
- Patients whose aneurysm judged appropriate for balloon-assisted coiling
- Patients whose aneurysm is bleeding from the "neck"
- Patients who are clinically judged to suffer imminent death within 24 hours.
- Pregnancy or positive urine pregnancy test
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07250958
Related Trials
Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
NCT0628464225 locations
Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH
NCT057380831 location
Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
NCT068634801 location
Microvention AnEurysm & STroke Real-life Data cOllection
NCT064944361 location
FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
NCT0640936416 locations